Early cancer diagnosis: The use of Raman spectroscopy in leading-edge biosensor development
Diagnosing most cancers at an early stage can have a profound impact on survival and life expectancy. If a malignant tumour has grown too big, or a cancer has spread, medical treatment becomes more difficult and the chances of surviving the disease are significantly reduced.
In a relatively short span of time, surface-enhanced Raman spectroscopy (SERS) has become a powerful tool in the development of innovative high-sensitivity biosensors capable of detecting and measuring cancer biomarkers at the earliest possible stage.
A pioneer in the field of SERS-based biosensor research, Singapore Bioimaging Consortium (SBIC) used Renishaw's inVia™ confocal Raman microscope to support this ground-breaking work.
- Case study: Early cancer diagnosis: The use of Raman spectroscopy in leading-edge biosensor development [2.5MB]
- Case study: Early cancer diagnosis: The use of Raman spectroscopy in leading-edge biosensor development [104kB]
- The use of Raman spectroscopy in leading-edge biosensor development [11.8MB]
- Biopolis, Singapore’s R&D hub for biomedical science and home to SBIC [16.2MB]
- Raman spectrometer in action [11.0MB]
For further images, videos, company biographies or information on Renishaw and its products, visit our Media Hub.